Cormorant Asset Management, LP — Form 4 insider transactions

Cormorant Asset Management, LP — Full 13F portfolio →

Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.

Transaction date Activity Security Shares Price Total Filing
2026-10-29 Sell Corbus Pharmaceuticals Holdings, Inc. 425,000 $4.10 $1,742,755 SEC filing
2026-08-10 Buy BlossomHill Therapeutics, Inc. 312,500 $16.00 $5,000,000 SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,701,541 — — SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,599,993 — — SEC filing
2026-04-28 Sell BRIGHT MINDS BIOSCIENCES INC. 109,331 $89.50 $9,785,124 SEC filing

How Form 4 differs from 13F

13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.

All insider transactions →